March 03, 2016 Adityarup “Rup” Chakravorty You are hungry. You get a can from the pantry or some leftovers from the fridge, warm up the food in the microwave and sit down to eat a …
Vision
David Gamm, MD, PhD
Title: Pharmacological modulation of photoreceptor outer segment degradation in Best disease patient-derived hiPSC-RPE Legend: (a) Representative western blot analysis comparing the amount of the POS protein RHO in untreated and VPA-treated (500 µmol/l) BD hiPSC-RPE at …
UW eye researchers publish second study of stem cells and blinding eye disease
A team of eye researchers at the University of Wisconsin-Madison have used a custom stem cell model of a rare but blinding eye disease to test whether a commonly used drug might offer hope for treatment.
Vision research month
June is Vision Research Awareness Month and the Waisman Center is home to a comprehensive vision research program led by David Gamm, MD, PhD. Gamm, a Waisman Center investigator, associate professor of ophthalmology and visual sciences, and Director of the McPherson Eye Research Institute, studies human retinal development and potential therapies for retinal degenerative diseases.
Gamm’s research aims to treat blinding diseases
Inherited and acquired degenerative diseases of the retina are a significant cause of incurable vision loss worldwide. David Gamm, MD, PhD, utilizes stem cell technology to test ways to preserve or restore vision in people …
Family supports UW-Madison research on eye disease
When Madison attorney David Walsh learned 17 years ago that his sons have a genetic disorder that causes blindness, he went into action mode.
A Promising Sight
But the specks in the Petri dishes were the result of years of research in the laboratory of David Gamm, an ophthalmologist at the UW’s Waisman Center. And as members of the Reese family carefully cradled the dishes, they held the future of their descendants’ eyesight in their hands.